The co-expression of cytokeratin and p63 in epithelioid angiosarcoma of the parotid gland: a diagnostic pitfall by unknown
Lin et al. Diagnostic Pathology 2012, 7:118
http://www.diagnosticpathology.org/content/7/1/118CASE REPORT Open AccessThe co-expression of cytokeratin and p63 in
epithelioid angiosarcoma of the parotid gland:
a diagnostic pitfall
Xu-Yong Lin1,2, Yang Liu1,2, Yong Zhang1,2, Juan-Han Yu1,2 and En-Hua Wang1,2*Abstract
Summary: Epithelioid angiosarcoma of the parotid gland is rare, and may pose a great diagnostic challenge. We
report a case of primary epithelioid angiosarcoma in a 64-year-old male without history of radiation. The
histopathological findings demonstrated a high grade epithelioid neoplasm. Immunostaining showed that the
tumor was positive for the pan-cytokeratin, p63, cytokeratin18, Vimentin and vascular markers CD31, and was
negative for CD34, cytokeratin5/6, cytokeratin7, cytokeratin20, CD68, CD30, S-100, HMB45, desmin, α–SMA and
CD45. The tumor was diagnosed as an epithelioid angiosarcoma. To our knowledge, this is the first reported case of
angiosarcoma which showed common positivity for cytokeratin and p63. In addition to cytokeratin, p63 is
considered a useful marker for carcinoma. The co-expression of cytokeratin and p63 in epithelioid angiosarcoma
represents a diagnostic pitfall. Thus, using a panel of antibodies is essential for distinguishing this tumor from
poorly differentiated carcinoma.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/6548916707504750
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Angiosarcoma predominantly arises in the skin or super-
ficial soft tissue. The majority of neoplasms of the parotid
gland are epithelial, while angiosarcoma, especially
epithelioid angiosarcoma is extremely rare [1,2]. Because
of its rarity, epitheloid angiosarcoma may be misdiag-
nosed as an epithelial tumor [3]. Angiosarcoma is a highly
aggressive tumor. Local recurrences develop in about one
fifth of patients and one half may be expected to die
within the first year after diagnosis with metastatic disease
in the lung followed by lymph node, bone, and soft tissue
[4]. So, it is necessary to distinguish epithelioid angiosar-
coma from poorly differentiated squamous cell carcinoma
or other epithelioid lesions. Here, we report a case of pri-
mary epithelioid angiosarcoma of the parotid gland in a* Correspondence: wangeh@hotmail.com
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reproduction in any medium, provided the or64-year-old Chinese male without history of radiation to
the head and neck.
Case history
A 64-year-old male without a previous history of malig-
nancy or radiation in the head and neck area presented
with a painful swelling of the right parotid gland. The
patient reported the parotid gland increased rapidly in
size. A parotidectomy was then performed in our hos-
pital. Three months later, the tumor recurred in the
same site, and then the tumor was excised again.
Methods
The resected specimens were fixed with 10% neutral-
buffered formalin and embedded in paraffin blocks. Tissue
blocks were cut into 4-μm slides, deparaffinized in xylene,
rehydrated with graded alcohols, and immunostained with
the following antibodies: pan-cytokeratin (pan-CK), cyto-
keratin 5/6 (CK 5/6), cytokeratin18 (CK18), p63, vimentin,
CD31, CD34, cytokeratin7 (CK7), cytokeratin20 (CK20),
S100, desmin, α–smooth muscle actin(α–SMA), CD45,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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a streptavidin-peroxidase system (KIT-9720, Ultrasensitive
TM S-P, MaiXin, China). The chromogen used was
diaminobenzidine tetrahydrochloride substrate (DAB kit,
MaiXin, China), slightly counterstained with hematoxylin,
dehydrated and mounted.
Results
Grossly, the resected parotid gland tissue measured
3.2×2.8× 1.6 cm with irregular shape, and was not well cir-
cumscribed, the cut surface showed grey-red or grey –white
in colour with focal hemorrhage. Histologically, the tumor
was made up of large round or polygonal epithelioid cells
which were predominantly arranged in solid sheets or nests.
The area of necrosis and hemorrhage could also be seen
easily. There was no area of spindle cells in the whole sec-
tion. The cells had pale to basophilic copious cytoplasm
and vesicular nuclei, prominent nucleoli with significant
anaplastic features. Focally, the tumor cells were arranged
into gaping vessel-like spaces or sinusoid-like spaces
(Figure 1).
Immunohistochemistry showed the tumor cells were
diffuse (over 50% of tumor cells) positive for pan-CK, p63
and Vimentin, CD31 was also strongly expressed in tumor
cells. In addition, a focal and weak immunostaining was
seen for CK18. The tumor cells were negative for CD34,
CK 5/6, CK7, CK20, S100, desmin, α–SMA, CD45, CD30,
CD68 and HMB45. Ki67 was expressed approximately in
50% of all tumor cells (Figure 2). According to the mor-
phological and immunohistochemical findings, the tumor
was diagnosed as an epithelioid angiosarcoma.Figure 1 A, The tumor cells were arranged in nests on the right area
left area (red arrow). B, The area of necrosis and hemorrhage could also
on peripheral area of the whole section. D, Solid areas showed anaplastic cDiscussion
Angiosarcoma predominantly arises in the skin or super-
ficial soft tissue. Less frequently, it can occur in various
organs and has been reported in ovary [5], oral cavity
[3], small intestine [6], thyroid [7], pleura [8], lung [9],
testis [10,11] and parotid [2,3], even in fibroadenoma
[12] and phyllodes tumour [13]. Occasionally, it also
may be part of dedifferentiated liposarcoma [14] or
mixed malignant tumors [15,16]. Epithelioid angiosar-
coma most commonly involves deep soft tissue. Histolo-
gically, epithelioid angiosarcoma predominantly consists
of sheets of highly atypical round cells with prominent
nuclei, resembling poorly differentiated carcinoma, so, it
may cause a great diagnostic confusion [4]. The diagno-
sis hint of angiosarcoma may be the existence of
sinusoid-like spaces or the remarkable necrosis or
hemorrhage. Unfortunately, there is a variant in squa-
mous cell carcinoma, namely, pseudoangiosarcomatous
cell carcinoma which also shows anastomosing vascular
and gland-like spaces mimicking angiosarcoma [17]. So,
in addition to histological findings, immunostaining
must be used for distinguishing the two entities.
The endothelial cells show reactivity for several mar-
kers, including CD31, CD34 and von Willebrand factor
(factor VIII). Among them, CD31 is considered the most
sensitive and most specific endothelial cell marker.
Epithelioid angiosarcoma is positive for CD31, but it is
classically negative for CD34. In our case, there was
strong and diffuse expression for CD31 in almost all
tumor cells, and CD34 expression was absent. So we
made the diagnosis of epithelioid angiosarcoma.(green arrow); while the normal parotid gland tissue was on the
be seen easily (black arrow). C, The large vascular spaces could be seen
ells with prominent nucleoli and no clear-cut vasoformation.
Figure 2 A, Diffuse pankeratin staining highlighted the tumor cells. B, The majority of the tumor cells was positive for p63. C, Diffuse and
strong expression of CD31could be seen in the tumor cells. D, Almost 50% of tumor cells were positive for Ki67.
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epithelioid angiosarcoma can express cytokeratin [18].
Miettinen M et al. found that epithelioid angiosarcomas
were often positive for CK8 and CK18 (approximately
50%) [18]. Therefore, CK may be not helpful in distin-
guishing epithelioid angiosarcoma from squamous cell
carcinoma. In our case, although CK showed a diffuse ex-
pression, but contrary to the diffuse and strong cyto-
keratin immunoreactivity in most of the carcinoma, the
staining seemed to be relatively weak. This may represent
an important clue to the possibility of non-epithelial
lesions.
P63 is a p53 homolog that is expressed in various nor-
mal epithelial tissues and epithelial malignancies [19,20].
Many pathologists believed that immunohistochemical
staining for p63 protein was a useful marker for distin-
guishing spindle cell carcinoma from sarcoma [21,22]. Jo
VY et al. also demonstrated that p63 immunohisto-
chemical staining is limited in soft tissue tumors, and
failed to find expression of P63 in 20 cases of angiosar-
comas [23]. On the contrary, in our case we found dif-
fuse p63 expression in the tumor cells. So far, there is
only one literature that described the positive expression
of p63 in angiosarcoma, that is, Kallen ME et al.
reported nuclear p63 expression might been seen in
20%–30% of malignant vascular tumors, including angio-
sarcoma, epithelioid angiosarcoma and epithelioid
hemangioendothelioma [24]. Senoo M et al. found that
p63 can affect expression of vascular endothelial growth
factor via interactions with hypoxia inducible factor-1α
[25]. Consequently, it is reasonable that p63 can express
in vascular tumors, and p63 may not be as specific forthe epithelial differentiation as the literatures reported
[21-23]. Moreover, in contrast to described by Kallen
ME et al. that only a minority of tumor cell nuclei
were immunoreactive in most p63-positive vascular
tumors [24], in our case over 75% of the tumor cells
was positive. The p63 expression in angiosarcoma
represents another diagnostic pitfall.
Conclusion
Because of the rarity and closely mimicking carcinoma,
epithelioid angiosarcoma is misdiagnosed easily, espe-
cially when one unfamiliar with this entity. CK and p63
are usually considered as the markers for carcinoma, but
our result indicates the co-expression of them can be
seen in angiosarcoma, this may be a further diagnostic
pitfall. To avoid the misdiagnosis, using a panel of anti-
bodies including endothelial cell markers is quite
essential.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in Chief of this Journal.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LXY participated in the histopathological evaluation, performed the literature
review, acquired photomicrographs and drafted the manuscript. LY carried
out the immunohistochemical stains evaluation. ZY and YJH conceived and
designed the study. WEH gave the final histopathological diagnosis and
Lin et al. Diagnostic Pathology 2012, 7:118 Page 4 of 4
http://www.diagnosticpathology.org/content/7/1/118revised the manuscript. All the authors read and approved the final
manuscript.
Received: 18 June 2012 Accepted: 10 August 2012
Published: 3 September 2012References
1. del Rio MJ P, Garcia-Garcia J, Diaz-Iglesias JM, Frasno MF: Radiation-
associated angiosarcoma involving the parotid gland. Histopathology
1998, 33:586–587.
2. Fanburg-Smith JC, Furlong MA, Childers EL: Oral and salivary gland
angiosarcoma: a clinicopathological study of 29 cases. Mod Pathol 2003,
16:263–271.
3. Terada T: Angiosarcoma of the oral cavity. Head Neck Pathol 2011,
5(1):67–70.
4. Fletcher CDM, Unni KK, Mertens F: World Health Organization classification of
tumours: pathology and genetics of tumours of soft tissue and bone. Lyon:
IARC Press; 2002.
5. Bösmüller H, Gruber C, Haitchi-Petnehazy S, Wagner D, Webersinke G,
Hauptmann S: Primary angiosarcoma of the ovary with prominent
fibrosis of the ovarian stroma. Case report of an 81-year old patient.
Diagn Pathol 2011, 6:65.
6. Delvaux V, Sciot R, Neuville B, Moerman P, Peeters M, Filez L, Van
Beckevoort D, Ectors N, Geboes K: Multifocal epithelioid angiosarcoma of
the small intestine. Virchows Arch 2000, 437(1):90–94.
7. Maiorana A, Collina G, Cesinaro AM, Fano RA, Eusebi V: Epithelioid
angiosarcoma of the thyroid. Clinicopathological analysis of seven cases
from non-Alpine areas. Virchows Arch 1996, 429(2–3):131–137.
8. Kao YC, Chow JM, Wang KM, Fang CL, Chu JS, Chen CL: Primary pleural
angiosarcoma as a mimicker of mesothelioma: a case report. Diagn
Pathol 2011, 6:130.
9. Pandit SA, Fiedler PN, Westcott JL: Primary angiosarcoma of the lung. Ann
Diagn Pathol 2005, 9:302–304.
10. Masera A, Ovcak Z, Mikuz G: Angiosarcoma of the testis. Virchows Arch
1999, 434(4):351–353.
11. Armah HB, Rao UN, Parwani AV: Primary angiosarcoma of the testis:
report of a rare entity and review of the literature. Diagn Pathol 2007,
2:23.
12. Babarović E, Zamolo G, Mustać E, Strčić M: High grade angiosarcoma
arising in fibroadenoma. Diagn Pathol 2011, 6:125.
13. Mamoon N, Mushtaq S, Hassan U, Rashid R, Khadim MT, Sarfraz T, Waqar
MA: Angiosarcoma arising in recurrent phyllodes tumour. Histopathology
2009, 54:913–916.
14. da Cunha IW, Kowalski LP, Soares FA: Dedifferentiated liposarcoma of the
oral cavity with angiosarcomatous dedifferentiation. Virchows Arch 2005,
446(4):456–459.
15. Ryan JF, Kealy WF: Concomitant angiosarcoma and carcinoma of the
breast: a case report. Histopathology 1985, 9:893–899.
16. Li YF, Yu CP, Wu ST, Dai MS, Lee HS: Malignant mesenchymal tumor with
leiomyosarcoma, rhabdomyosarcoma, chondrosarcoma, and
osteosarcoma differentiation: case report and literature review. Diagn
Pathol 2011, 6:35.
17. Terada T: Papillary squamous cell carcinoma of the oral cavity with
acantholytic and pseudovascular features. Int J Clin Exp Pathol 2011, 4
(8):794–796.
18. Miettinen M, Fetsch JF: Distribution of keratins in normal endothelial cells
and a spectrum of vascular tumors: implications in tumor diagnosis.
Hum Pathol 2000, 31:1062–1067.
19. Laurikkala J, Mikkola ML, James M, Tummers M, Mills AA, Thesleff I: P63
regulates multiple signalling pathways required for ectodermal
organogenesis and differentiation. Development 2006, 133(8):1553–1563.
20. Nekulova M, Holcakova J, Coates P, Vojtesek B: The role of P63 in cancer,
stem cells and cancer stem cells. Cell Mol Biol Lett 2011, 16(2):296–327.
21. Dotto JE, Glusac EJ: P63 is a useful marker for cutaneous spindle cell
squamous cell carcinoma. J Cutan Pathol 2006, 33(6):413–417.
22. Kurian KM, Al-Nafussi A: Sarcomatoid/metaplastic carcinoma of the breast:
a clinicopathological study of 12 cases. Histopathology 2002, 40(1):58–64.
23. Jo VY, Fletcher CDM: P63 immunohistochemical staining is limited in soft
tissue tumors. Mod Pathol 2011, 24(1S):15A.24. Kallen ME, Nunes Rosado FG, Gonzalez AL, Sanders ME, Cates JM:
Occasional staining for p63 in malignant vascular tumors: a potential
diagnostic pitfall. Pathol Oncol Res 2012, 18:97–100.
25. Senoo M, Matsumura Y, Habu S: Ap63γ (p51A) and dNp63α (p73L), two
major isoforms of the p63 gene, exert opposite effects on the vascular
endothelial growth factor (VEGF) gene expression. Oncogene 2002, 21
(16):2455–2465.
doi:10.1186/1746-1596-7-118
Cite this article as: Lin et al.: The co-expression of cytokeratin and p63
in epithelioid angiosarcoma of the parotid gland: a diagnostic pitfall.
Diagnostic Pathology 2012 7:118.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
